Last deal

Amount

Series A

Stage

31.12.2014

Date

1

all rounds

General

About Company
nanoRETE is developing a nanoparticle-based biosensor technology platform for real-time pathogen detection.

Industry

Sector :

Subsector :

Keywords :

Last funding type

Series A

IPO status

Private
Contacts